| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.981 | 2.863 | 3.512 | 2.824 | 1.831 | 2.719 | 2.868 | 3.390 | 2.971 | 2.705 |
| Total Income - EUR | 1.981 | 2.863 | 3.512 | 2.824 | 1.831 | 2.719 | 2.868 | 3.390 | 2.971 | 2.705 |
| Total Expenses - EUR | 629 | 454 | 1.016 | 691 | 703 | 707 | 1.803 | 1.232 | 10.328 | 1.039 |
| Gross Profit/Loss - EUR | 1.352 | 2.409 | 2.496 | 2.133 | 1.129 | 2.012 | 1.065 | 2.158 | -7.357 | 1.666 |
| Net Profit/Loss - EUR | 1.292 | 2.323 | 2.390 | 2.048 | 1.074 | 1.933 | 979 | 2.061 | -7.580 | 1.405 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alindor Farmacie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.208 | 1.196 | 1.176 | 1.154 | 1.132 | 1.110 | 0 | 0 | 0 | 0 |
| Current Assets | 12.609 | 12.419 | 13.020 | 11.969 | 12.751 | 14.798 | 15.065 | 17.373 | 7.541 | 8.803 |
| Inventories | 12.598 | 12.399 | 12.189 | 11.965 | 11.733 | 11.511 | 11.256 | 11.291 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 2 | 2 | 309 | 5.883 | 6.636 | 8.750 |
| Cash | 10 | 20 | 830 | 3 | 1.015 | 3.285 | 3.499 | 199 | 904 | 53 |
| Shareholders Funds | 3.141 | 5.432 | 7.730 | 9.636 | 10.524 | 12.257 | 12.964 | 15.066 | 7.440 | 8.804 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.676 | 8.183 | 6.466 | 3.487 | 3.359 | 3.652 | 2.100 | 2.308 | 101 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Alindor Farmacie Srl